Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
Objectives: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. Case report: The patient is a 33yo male who experienced an episo...
Main Authors: | Josef Finsterer, Sebastian Nics |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2022-03-01
|
Series: | Brain Hemorrhages |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589238X21000668 |
Similar Items
-
SARS-CoV-2 may underlie NMDA-related autoimmune encephalitis and venous sinus thrombosis
by: Josef Finsterer
Published: (2023-06-01) -
Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit
by: Josef Finsterer
Published: (2022-03-01) -
Beyond Eclampsia: Cerebral Venous Sinus Thrombosis Presenting With Headache and Seizure in a Postpartum Patient
by: Kriti Bhatia
Published: (2014-08-01) -
Persisting, unilateral tinnitus 22 days after first dose of an mRNA-based SARS-CoV-2 vaccine
by: Josef Finsterer, et al.
Published: (2022-01-01) -
Before blaming SARS-CoV-2 for venous sinus thrombosis in a septic patient, consider alternative etiologies
by: Josef Finsterer, et al.
Published: (2023-03-01)